GAVI Alliance pledges up to $162M to control, prevent measles outbreaks in developing countries

NewsGuard 100/100 Score

"Seeking to address the devastating resurgence of measles, the GAVI Alliance will provide up to an additional $162 million to control and prevent outbreaks in developing countries," a GAVI press release reports, noting, "This funding will help countries bridge critical gaps in their efforts to build sustainable systems to control this deadly disease." According to the press release, GAVI will "make up to $107 million available for measles control and prevention in six high-risk countries: Afghanistan, Chad, DR Congo, Ethiopia, Nigeria, and Pakistan," and an additional "$55 million will be offered through the Measles & Rubella Initiative for rapid response vaccination campaigns in GAVI-eligible countries where outbreaks occur" (6/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MMR vaccine slashes antibiotic use in toddlers: Nordic study shines light on broader benefits